1. Home
  2. AGIO vs ARCO Comparison

AGIO vs ARCO Comparison

Compare AGIO & ARCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$27.25

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Arcos Dorados Holdings Inc. Shares

ARCO

Arcos Dorados Holdings Inc. Shares

HOLD

Current Price

$8.79

Market Cap

1.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGIO
ARCO
Founded
2007
2007
Country
United States
Uruguay
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
2013
2011

Fundamental Metrics

Financial Performance
Metric
AGIO
ARCO
Price
$27.25
$8.79
Analyst Decision
Buy
Hold
Analyst Count
8
2
Target Price
$38.88
$8.60
AVG Volume (30 Days)
1.3M
1.0M
Earning Date
04-29-2026
05-20-2026
Dividend Yield
N/A
3.23%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,011,000.00
N/A
Revenue This Year
$76.75
$12.56
Revenue Next Year
$170.73
$3.48
P/E Ratio
N/A
$7.26
Revenue Growth
N/A
N/A
52 Week Low
$22.24
$6.51
52 Week High
$46.00
$9.75

Technical Indicators

Market Signals
Indicator
AGIO
ARCO
Relative Strength Index (RSI) 43.00 50.41
Support Level $26.03 $7.04
Resistance Level $29.69 $8.98
Average True Range (ATR) 1.36 0.31
MACD -0.19 -0.07
Stochastic Oscillator 25.72 20.08

Price Performance

Historical Comparison
AGIO
ARCO

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

About ARCO Arcos Dorados Holdings Inc. Shares

Arcos Dorados Holdings Inc operates McDonald's branded restaurants in various countries and territories in Latin America and the Caribbean. The Company manages its business as distinct geographic segments and its operations are divided into three geographic divisions, as follows: Brazil, the North Latin American division, or NOLAD, which is comprised of Costa Rica, Mexico, Panama, Puerto Rico, Martinique, Guadeloupe, French Guiana and the U.S. Virgin Islands of St. Croix and St. Thomas and the South Latin American division, or SLAD, which is comprised of Argentina, Chile, Ecuador, Peru, Uruguay, Colombia, Venezuela, Trinidad and Tobago, Aruba and Curacao. Their menu includes hamburgers, McNuggets, salad, sandwiches, French fries, and others.

Share on Social Networks: